FDA Approves Clinical Trials For Lagundi As COVID-19 Treatment
LAGUNDI – The Food and Drug Administration (FDA) approved the clinical trials for Lagundi as a supplemental treatment for COVID-19.
The plant has been one of the most used treatments for ailments in the Philippines, especially for flu-like symptoms. According to researchers, the Lagundi would be administered to patients with mild symptoms who are admitted to quarantine centers.
According to an article from Inquirer, Department of Science and Technology (DOST) Secretary Fortunato Dela Peña stated:
Ang hangad natin ay ma-address ang symptoms gaya ng ubo, lagnat at mga sore throat. Kasi malaking bagay kung giginhawa ang ating pasyente na mild cases dyan sa mga symptoms na ‘yan.
Lagundi has long been proven as an effect treatment for cough, one of the most common symptoms for the new respiratory disease. Along with this, the DOST is also conducting clinical trials for Virgin Coconut Oil to study its effectiveness against the virus.
Virgin coconut oil has a natural antiseptic that researchers said could potentially kill the virus. Along with this, it also strengthens the body’s immune system to further protect it from the new coronavirus, COVID-19.
As per the article, Dela Peña said the trials would have participants from three quarantine centers, the Quezon Institute quarantine center, Sta. Ana Hospital, and Philippine National Police-National Capital Region community quarantine center.
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.
Like this article? READ ALSO: DOST Trials On VCO: Can Possibly “Directly Kill Or Destroy Virus”
